Equities

Retractable Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Retractable Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.65
  • Today's Change0.00 / 0.00%
  • Shares traded50.13k
  • 1 Year change-17.72%
  • Beta1.2694
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.

  • Revenue in USD (TTM)37.90m
  • Net income in USD-6.68m
  • Incorporated1994
  • Employees221.00
  • Location
    Retractable Technologies Inc511 Lobo LaneLITTLE ELM 75068-5295United StatesUSA
  • Phone+1 (972) 294-1010
  • Fax+1 (972) 292-3600
  • Websitehttps://retractable.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BioNano Genomics Inc28.72m-38.59m11.45m98.00--0.2198--0.3986-737.92-737.929.995.120.34511.455.84293,061.20-46.37-58.31-69.84-72.5345.9718.60-134.36-487.421.82--0.07---14.7924.8951.82--11.02--
Nexalin Technology Inc156.94k-8.68m11.56m6.00--2.37--73.69-0.6345-0.63450.01090.26220.03020.300413.5926,156.67-167.17-166.16-178.46-334.5469.5176.06-5,530.09-1,178.9513.03--0.00--52.34-4.04-63.64------
BioRegenx Inc1.93m-18.93m12.50m5.00------6.48-0.0195-0.01950.002-0.00380.20833.1547.03385,874.00-204.29---341.72--78.14---980.96--0.0416-8.01-----31.40---540.38------
Trinity Biotech PLC (ADR)49.41m-35.91m13.07m401.00------0.2645-2.19-2.223.19-2.570.50941.523.48123,217.00-37.02-23.08-52.54-35.9733.8138.51-72.67-32.840.4083-1.731.79--8.31-7.4115.33---3.22--
Vicarious Surgical Inc0.00-53.59m13.17m123.00--0.7826-----9.04-9.040.002.360.00----0.00-97.47-35.33-109.17-37.33------------0.00------11.04---6.06--
Vivos Therapeutics Inc17.32m-17.10m14.16m109.00--4.90--0.8175-1.88-1.881.930.30630.8449--13.38158,871.60-83.45-85.27-120.33-138.5155.7467.27-98.77-108.16----0.7785--8.915.7018.02--26.46--
United Health Products Inc0.00-2.95m15.03m10.00---------0.0116-0.01160.00-0.01290.00----0.00-2,405.94-4,956.01-----------137,625.90---16.29--------23.69------
Envoy Medical Inc208.00k-28.61m15.26m42.00------73.35-1.44-1.440.0103-0.32180.02370.501.794,952.38-247.90-------294.23---10,475.00--0.4582-14.86-----28.80--10.55------
Retractable Technologies Inc37.90m-6.68m19.46m221.00--0.254223.410.5134-0.223-0.2231.272.560.24921.864.43171,495.80-4.248.45-4.509.59-2.4238.19-17.0115.054.54--0.0126---24.19-4.59-67.29--17.90--
Milestone Scientific Inc8.93m-6.67m20.05m17.00--7.86--2.25-0.0823-0.08230.10990.03250.90840.489614.06525,265.90-67.82-48.29-122.68-62.1471.8665.25-74.66-81.560.5103-837.640.2518---12.190.602731.97--0.40--
Harvard Bioscience Inc87.37m-53.84m21.11m330.00--1.50--0.2416-1.22-1.221.980.31560.83521.587.01264,760.60-51.46-4.48-81.52-5.4756.9457.18-61.62-6.180.4081-0.56860.7071---16.14-4.12-263.25--21.83--
Adagio Medical Holdings Inc137.00k-79.15m21.39m86.00------156.14-4.75-4.750.0087-0.08530.0020.75583.041,593.02-114.09---130.69---1,468.61---57,771.53--0.6798-4.931.07--100.67---105.09------
Jin Medical International Ltd22.83m1.79m22.26m269.0012.420.797511.280.97520.01150.01150.14580.17830.5093.264.1584,857.363.8510.686.3416.5135.7934.537.5513.921.90--0.36170.0018.572.9027.710.155496.27--
Inspira Technologies Oxy BHN Ltd289.00k-11.21m23.22m38.00--14.57--80.33-0.4606-0.46060.01280.04460.04170.52810.66597,605.26-161.61-109.16-302.02-145.380.692---3,879.24--0.9002--0.00------2.06--39.54--
Global Innovative Platforms Inc0.00-718.26k23.84m52.00--120.87-----0.0179-0.01790.000.00420.00-------720.78---929.61--------------0.0079-------427.35------
IRIDEX Corp50.65m-5.09m24.58m93.00------0.4854-0.3026-0.30263.020.27461.733.437.74544,591.40-17.39-20.28-33.62-29.9638.1842.41-10.04-15.171.35--0.4418---6.172.306.90---36.71--
Data as of Feb 06 2026. Currency figures normalised to Retractable Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

7.03%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 2025581.74k1.94%
Renaissance Technologies LLCas of 30 Sep 2025427.56k1.43%
Eversept Partners LPas of 30 Sep 2025363.32k1.21%
BlackRock Fund Advisorsas of 30 Sep 2025241.12k0.81%
Geode Capital Management LLCas of 30 Sep 2025128.11k0.43%
Bridgeway Capital Management LLCas of 30 Sep 202588.54k0.30%
Vanguard Fiduciary Trust Co.as of 31 Dec 202585.26k0.29%
RBF Capital LLCas of 30 Sep 202566.31k0.22%
Citadel Securities LLCas of 30 Sep 202562.41k0.21%
SSgA Funds Management, Inc.as of 30 Sep 202559.80k0.20%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.